Benzodiazepine Withdrawal Phenomena
The DOI matches its Crossref record.
Abstract
A withdrawal syndrome is described in 10 patients who claimed to be unable to discontinue benzodiazepines. A high dose group took the equivalent of a mean of 135 mg diazepam/day, and the normal dose group of 20 mg/day. Associated with the gradual reduction of medication was the emergence of severe symptoms of anxiety as well as sensory intolerance, perceptual disturbances and weight loss. The withdrawal syndrome subsided after 2 weeks and was similar in both groups of patients. EEG changes were detected on withdrawal opposite to those known to be associated with initiation of diazepam treatment. The measures tended to revert to the baseline after a drug-free period. One reason why chronic users of diazepam experience difficulty in stopping medication may be the development of a withdrawal syndrome even after moderate dosage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, symptoms that persisted for months or even years after complete benzodiazepine discontinuation were observed decades ago [5, 6].”
From Long-term consequences of benzodiazepine-induced neurological dysfunction: A survey (2023) · cites this paper as [5]
Citations
Cites
Still being checked.
Cited by
Jerram, T. C. (1981) · Side Effects of Drugs Annual · doi:10.1016/s0378-6080(81)80009-8 · Cited by 690
Guidelines for the Rational Use of Benzodiazepines: When and What to Use
Ashton, H. (1994) · Drugs · doi:10.2165/00003495-199448010-00004 · Cited by 593
Benzodiazepines revisited—will we ever learn?
Lader, M. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03563.x · Cited by 573
Self-citationBenzodiazepine use, abuse, and dependence.
O’Brien, C. P. (2005) · PubMed · Cited by 539
The diagnosis and management of benzodiazepine dependence
Ashton, H. (2005) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000165594.60434.84 · Cited by 455
Current Status of Benzodiazepines
Koch-Weser, J., Greenblatt, D. J., Shader, R. I., & Abernethy, D. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090705 · Cited by 451
Benzodiazepine withdrawal: an unfinished story.
Ashton, H. (1984) · BMJ · doi:10.1136/bmj.288.6424.1135 · Cited by 291
Classics in Chemical Neuroscience: Diazepam (Valium)
Calcaterra, N. E., & Barrow, J. C. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn5000056 · Cited by 281
The benzodiazepine withdrawal syndrome
PÉTURSSON, H. (1994) · Addiction · doi:10.1111/j.1360-0443.1994.tb03743.x · Cited by 246
Dell’osso, B., & Lader, M. (2013) · European Psychiatry · doi:10.1016/j.eurpsy.2011.11.003 · Cited by 210
“per day of diazepam and equivalent doses of lorazepam or alprazolam [73,111].”
BackgroundSelf-citationPecknold, J. C. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290043006 · Cited by 204
Montgomery, S. A., Kennedy, S. H., Burrows, G. D., Lejoyeux, M., & Hindmarch, I. (2004) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000137184.64610.c8 · Cited by 196
Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.7.848 · Cited by 176
Protracted withdrawal syndromes from benzodiazepines
Ashton, H. (1991) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(91)90023-4 · Cited by 170
The Pharmacology of Benzodiazepines
Miller, N. S. (1991) · Springer eBooks · doi:10.1007/978-1-4612-3044-1_12 · Cited by 147
History of benzodiazepine dependence
LADER, M. H. (1991) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(91)90027-8 · Cited by 129
Self-citationBenzodiazepine withdrawal: Overview and implications for the treatment of anxiety
Roy‐Byrne, P., & Hommer, D. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90309-9 · Cited by 123
Use and abuse of benzodiazepines. Issues relevant to prescribing
Woods, J. H., Katz, J. L., & Winger, G. (1988) · JAMA · doi:10.1001/jama.260.23.3476 · Cited by 99
CLINICAL EVALUATION OF A SPECIFIC BENZODIAZEPINE ANTAGONIST (RO 15-1788)
Ricou, B., Forster, A., BRÜCKNER, A., Chastonay, P., & GEMPERLE, M. (1986) · British Journal of Anaesthesia · doi:10.1093/bja/58.9.1005 · Cited by 92
Kan, C. C., Hilberink, S. R., & Breteler, M. H. M. (2004) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2003.12.007 · Cited by 81
Benzodiazepine Withdrawal Syndrome: A Literature Review and Evaluation
Mackinnon, G. L., & Parker, W. A. (1982) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952998209002608 · Cited by 81
GABA-Ergic Drugs: Exit Stage Left, Enter Stage Right
Ashton, H., & Young, A. H. (2003) · Journal of Psychopharmacology · doi:10.1177/0269881103017002004 · Cited by 81
Anxiolytic drugs: dependence, addiction and abuse
LADER, M. H. (1994) · European Neuropsychopharmacology · doi:10.1016/0924-977x(94)90001-9 · Cited by 81
Self-citationPower, K. G., Jerrom, D. W., Simpson, R. J., & Mitchell, M. (1985) · BMJ · doi:10.1136/bmj.290.6477.1246 · Cited by 78
WITHDRAWAL SYMPTOMS AFTER SIX WEEKS' TREATMENT WITH DIAZEPAM
Murphy, S., Owen, R. T., & Tyrer, P. J. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92075-0 · Cited by 76
Depression following withdrawal from long-term benzodiazepine use: a report of four cases
Olajide, D., & Lader, M. (1984) · Psychological Medicine · doi:10.1017/s0033291700019899 · Cited by 69
Self-citationAdverse effects of Benzodiazepines
Gudex, C. M. (1991) · Social Science & Medicine · doi:10.1016/0277-9536(91)90216-y · Cited by 68
Withdrawing Benzodiazepines in Patients With Anxiety Disorders
Lader, M., & Kyriacou, A. (2016) · Current Psychiatry Reports · doi:10.1007/s11920-015-0642-5 · Cited by 67
Self-citationThe biological basis of benzodiazepine dependence
Lader, M., & File, S. (1987) · Psychological Medicine · doi:10.1017/s0033291700025794 · Cited by 59
Self-citationLong-term effects of benzodiazepines
LADER, M. H., & Pétursson, H. (1983) · Neuropharmacology · doi:10.1016/0028-3908(83)90173-9 · Cited by 52
Self-citationDiazepam, Propranolol and their Combination in the Management of Chronic Anxiety
Hallstrom, C., Treasaden, I., Edwards, J. G., & Lader, M. (1981) · British Journal of Psychiatry · doi:10.1192/bjp.139.5.417 · Cited by 48
Self-citationLADER, M. H. (1984) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(84)90139-8 · Cited by 48
Self-citationA Controlled Trial of Dothiepin and Placebo in Treating Benzodiazepine Withdrawal Symptoms
Tyrer, P., Ferguson, B., Hallström, C., Michie, M., Tyrer, S., Cooper, S., Caplan, R., & Barczak, P. (1996) · British Journal of Psychiatry · doi:10.1192/bjp.168.4.457 · Cited by 46
Phenomenology and treatment of tremor disorders
Zesiewicz, T. A., & Hauser, R. A. (2001) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70039-6 · Cited by 43
Liebrenz, M., Gehring, M.-T., Buadze, A., & Caflisch, C. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0493-y · Cited by 41
Overview of pharmacotherapy: current status and future directions
Aman, M. G. (1987) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.1987.tb01349.x · Cited by 39
Long-term consequences of benzodiazepine-induced neurological dysfunction: A survey
Ritvo, A. D., Foster, D. E., Huff, C., Finlayson, A. J. R., Silvernail, B., & Martin, P. R. (2023) · PLOS ONE · doi:10.1371/journal.pone.0285584 · Cited by 38
“As far back as 1981, Hallström and Lader found elevated Hamilton anxiety scores several months after patients had withdrawn from benzodiazepines [5].”
BackgroundBenzodiazpine withdrawal effects
Pecknold, J. C., McClure, D. J., Fleuri, D., & Chang, H. (1982) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(82)80142-5 · Cited by 37
The natural history of tolerance to the benzodiazepines
Higgitt, A., Fonagy, P., & Lader, M. (1988) · Psychological Medicine. Monograph Supplement · doi:10.1017/s0264180100000412 · Cited by 37
Self-citationNeuromusclar Blocking Agents and Sedative Drags
Durbin, C. G. (1991) · Critical Care Clinics · doi:10.1016/s0749-0704(18)30292-6 · Cited by 37
Discontinuation reactions to alprazolam in panic disorder
Pecknold, J. C. (1993) · Journal of Psychiatric Research · doi:10.1016/0022-3956(93)90025-w · Cited by 36
Reversal by alpha-2 agonists of diazepam withdrawal hyperactivity in rats
Kunchandy, J., & Kulkarni, S. K. (1986) · Psychopharmacology · doi:10.1007/bf00181241 · Cited by 35
Behavioral pharmacology of minor tranquilizers
File, S. E., & Pellow, S. (1987) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(87)90097-0 · Cited by 33
Protracted Withdrawal From Benzodiazepines: The Post-Withdrawal Syndrome
Ashton, H. (1995) · Psychiatric Annals · doi:10.3928/0048-5713-19950301-11 · Cited by 32
Benzodiazepine dependence and withdrawal: identification and medical management.
Landry, M. J., Smith, D. E., Mcduff, D. R., & Baughman, O. L. (1992) · PubMed · Cited by 31
Treatment of benzodiazepine withdrawal symptoms with carbamazepine
García-Borreguero, D., Bronisch, T., Apelt, S., Yassouridis, A., & Emrich, H. M. (1991) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02219713 · Cited by 30
Long‐term use of benzodiazepines in psychiatric inpatients
Laux, G., & König, W. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb02863.x · Cited by 29
Characterization of benzodiazepine withdrawal in high- and low-dose dependent psychiatric inpatients
Schmauss, C., Apelt, S., & Emrich, H. M. (1987) · Brain Research Bulletin · doi:10.1016/0361-9230(87)90109-2 · Cited by 29
Murakoshi, A., Takaesu, Y., Komada, Y., Ishikawa, J., & Inoue, Y. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.11.003 · Cited by 28
A n evaluation of D SM‐III‐ R benzodiazepine dependence criteria Rasch m odelling and IC D‐10 using
Kan, C. C., Breteier, M. H. M., van der Ven, A. H. G. S., & Zitman, F. G. (1998) · Addiction · doi:10.1046/j.1360-0443.1998.9333494.x · Cited by 28
Sedation of the Agitated, Critically Ill Patient Without an Artificial Airway
Durbin, C. G. (1995) · Critical Care Clinics · doi:10.1016/s0749-0704(18)30046-0 · Cited by 26
Introduction benzodiazepines: A major problem
Miller, N. S., & Gold, M. S. (1991) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(91)90021-2 · Cited by 26
Benzodiazepines: Tolerance, Dependence, Abuse, and Addiction
Miller, N. S., & Gold, M. S. (1990) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1990.10472194 · Cited by 25
Abuse, Addiction, Tolerance, and Dependence to Benzodiazepines in Medical and Nonmedical Populations
Miller, N. S., & Gold, M. S. (1991) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999108992807 · Cited by 25
Other Psychotropic Drugs: Stimulants, Antidepressants, the Anxiolytics, and Lithium Carbonate
Chandler, M., Gualtieri, C. T., & Fahs, J. J. (1988) · Springer eBooks · doi:10.1007/978-1-4613-8774-9_6 · Cited by 25
Anxiolytic and hypnotic drug misuse in Thailand: Findings from a national household survey
Assanangkornchai, S., Sam‐angsri, N., RERNGPONGPAN, S., & EDWARDS, J. G. (2010) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2009.00092.x · Cited by 22
The Nature and Extent of Benzodiazepine Abuse: An Overview of Recent Literature
Dietch, J. T. (1983) · Psychiatric Services · doi:10.1176/ps.34.12.1139 · Cited by 21
FLUMAZENIL: A POSSIBLE TREATMENT FOR BENZODIAZEPINE WITHDRAWAL ANXIETY
File, S. E., & Baldwin, H. A. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92779-6 · Cited by 21
Pomara, N., Willoughby, L. M., Ritchie, J., Sidtis, J. J., Greenblatt, D. J., & Nemeroff, C. B. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300365 · Cited by 20
Short-acting versus long-acting benzodiazepines: Discontinuation effects in panic disorders
Burrows, G. D., Norman, T. R., Judd, F. K., & Marriott, P. F. (1990) · Journal of Psychiatric Research · doi:10.1016/0022-3956(90)90037-q · Cited by 20
A neuroendocrine approach to benzodiazepine tolerance and dependence.
Pétursson, H., Shur, E., Checkley, S., Slade, A., & LADER, M. H. (1981) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1981.tb01164.x · Cited by 20
Self-citationLong-term drug treatment of panic disorder
Burrows, G. D., Judd, F. K., & Norman, T. R. (1993) · Journal of Psychiatric Research · doi:10.1016/0022-3956(93)90022-t · Cited by 19
Addiction to and dependence on benzodiazepines
Miller, N. S., & Mahler, J. C. (1991) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(91)90028-9 · Cited by 19
Onyett, S. R., & Turpin, G. (1988) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s0141347300014154 · Cited by 17
Benzodiazepine dependent patients and their psychological treatment
Crouch, G., Robson, M., & Hallström, C. (1988) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(88)90109-1 · Cited by 17
The Role of Craving in Relapse After Discontinuation of Long-Term Benzodiazepine Use
Mol, A. J. J., & Voshaar, R. C. O. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n1209 · Cited by 16
Survival analytic approach to long‐term prescription of benzodiazepine hypnotics
Ishigooka, J., SUGIYAMA, T., SUZUKI, M., Kobayashi, K., Takeuchi, H., & Murasaki, M. (1998) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.1998.00422.x · Cited by 16
Hippocampus and locus coeruleus activity on rats chronically treated with diazepam
Pérez, M. F., Nasif, F. J., Marchesini, G. R., Maglio, L. E., & Ramírez, O. A. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00517-2 · Cited by 16
Changes in GABAA Receptor Function and Cross‐Tolerance to Ethanol in Diazepam‐Dependent Rats
Toki, S., Saito, T., Nabeshima, A., Hatta, S., Watanabe, M., & Takahata, N. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01726.x · Cited by 16
Acute and chronic glue sniffing effects and consequences of withdrawal on aggressive behavior
Bouchatta, O., Ouhaz, Z., Ba-M’hamed, S., Kerekes, N., & Bennis, M. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.03.013 · Cited by 15
Benzodiazepine dependence: detoxification under standardized conditions
Brenner, P. M., Wolf, B., Rechlin, T., Kauert, G. F., Rüther, E., & Hippius, H. (1991) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(91)90049-5 · Cited by 15
Midazolam oral self-administration
Falk, J. L., & Tang, M. (1985) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(85)90039-0 · Cited by 15
Graham, D. L., & Diaz‐Granados, J. L. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.05.024 · Cited by 15
Long-term Benzodiazepine Administration Blunts Growth Hormone Response to Diazepam
Shur, E., Petursson, H., Checkley, S., & Lader, M. H. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790090067010 · Cited by 15
Self-citationBenzodiazepine usage amongst the elderly: Findings of the liverpool community survey
Sullivan, C. F., Copeland, J. R. M., Dewey, M. E., Davidson, I. A., McWilliam, C., Saunders, P., Sharma, V. K., & Voruganti, L. N. P. (1988) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.930030409 · Cited by 15
Alternative treatments for withdrawing the long-term benzodiazepine user: a pilot study
Nathan, R. G., Robinson, D., Cherek, D. R., Sebastian, C. S., Hack, M., & Davison, S. (1986) · International Journal of the Addictions · doi:10.3109/10826088609063450 · Cited by 14
Megadose Clonazepam Dependence: A Case Report
Mowla, A., Firoozabadi, A., Borhani‐Haghighi, A., & Sahraian, A. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181506e4e · Cited by 14
Electroencephalographic Studies of Substance Use and Abuse
Bauer, L. O. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-021-6_4 · Cited by 14
Toki, S., Saito, T., Hatta, S., & Takahata, N. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00494-8 · Cited by 14
Chand, P., & Murthy, P. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00559.x · Cited by 13
Reduction of aggression during benzodiazepine withdrawal: Effects of flumazenil
Saxon, L., Borg, S., & Hiltunen, A. J. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.04.023 · Cited by 12
Pomara, N., Willoughby, L. M., Ritchie, J., Sidtis, J. J., Greenblatt, D. J., & Nemeroff, C. B. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0088-2 · Cited by 12
O'Sullivan, G. H., Swinson, R., Kuch, K., Marks, I. M., Basoglu, M., & Noshirvani, H. (1996) · Journal of Psychopharmacology · doi:10.1177/026988119601000204 · Cited by 10
Imidazenil: An antagonist of the sedative but not the anticonvulsant action of diazepam
Auta, J., Costa, E., DAVIS, J., & Guidotti, A. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.04.005 · Cited by 10
Lack of Sex Differences in Anxiety Behaviors During Precipitated Benzodiazepine Withdrawal in Rats
Stock, H. S., Ford, K., Biscardi, R., & Wilson, M. A. (1999) · Physiology & Behavior · doi:10.1016/s0031-9384(98)00286-8 · Cited by 10
Drug Development Optimization — Benzodiazepines
LADER, M. H. (1990) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7292-8_6 · Cited by 10
Self-citationVerhey, F. R. J., JOLLES, J., Ponds, R., de Lugt, M., Vreeling, F. W., Wattis, J. P., Spencer, G., & Yuvarajan, R. (1995) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.930101015 · Cited by 10
Theory and practice in managing benzodiazepine dependence and misuse
Seivewright, N. (1998) · Journal of Substance Misuse · doi:10.3109/14659899809053495 · Cited by 9
Development of a new benzodiazepine hypnotics withdrawal symptom scale
Kobayashi, M., Okajima, I., Narisawa, H., Kikuchi, T., Matsui, K., Inada, K., Ishigooka, J., & Inoue, Y. (2018) · Sleep and Biological Rhythms · doi:10.1007/s41105-018-0151-0 · Cited by 8
Dorsal Raphe and Substantia Nigra Response to Flumazenil in Diazepam-Dependent Rats
Wala, E. P., Sloan, J. W., & Jing, X. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00013-0 · Cited by 8
Feet, P. O., Larsen, S., Lillevold, P. E., & Robak, O. H. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb06345.x · Cited by 8
Klassifikatorische Probleme von Mißbraueh und körperlicher Abhängigkeit bei Benzodiazepinen
Philipp, M. E., & Buller, R. (1986) · Springer eBooks · doi:10.1007/978-3-642-70621-9_27 · Cited by 8
Cassano, G., Petracca, A., Borghi, C., Chiroli, S., Didoni, G., & Garreau, M. (1996) · European Psychiatry · doi:10.1016/0924-9338(96)84786-9 · Cited by 7
MacDonald, T., Gallo, A. T., Basso-Hulse, G., & Hulse, G. K. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109517 · Cited by 7
Sloan, J. W., Wala, E. P., Jing, X., Holtman, J. R., & Milliken, B. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00085-9 · Cited by 7
Benzodiazepine: Abhängigkeit und Entzugssyndrome — Klassifikation, Klinik und Therapie
Soyka, M. (1990) · Springer eBooks · doi:10.1007/978-3-642-75004-5_14 · Cited by 6
Jerram, T. C. (1984) · Side effects of drugs annual · doi:10.1016/s0378-6080(84)80009-4 · Cited by 6
Ankier, S. I., & Leonard, B. E. (1986) · International review of neurobiology · doi:10.1016/s0074-7742(08)60109-9 · Cited by 6
Manic-like Reaction Induced by Lorazepam Withdrawal *
Lapierre, Y. D., & Labelle, A. (1987) · The Canadian Journal of Psychiatry · doi:10.1177/070674378703200812 · Cited by 5
Two Kinds of Spatiotemporal EEG Changes after Discontinuation of Benzodiazepine, Medazepam
Manmaru, S., & Matsuura, M. (1990) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1990.tb00445.x · Cited by 5
Metadata
- Authors
- Hallstrom, C., & Lader, M.
- Venue
- International Pharmacopsychiatry
- Publisher
- S. Karger AG
- Published
- 2017-08-11
- Volume
- 16
- Issue
- 4
- Pages
- 235-244
- ISSN
- 0020-8272 (ISSN-L)
- 2504-2580
- OpenAlex
- W2418562842
- Cited by
- 132
- References
- 0
- Citations by year
- 2023: 2 · 2022: 1 · 2020: 1 · 2019: 1 · 2018: 2
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- International Pharmacopsychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- benzodiazepine withdrawal syndrome, diazepam, withdrawal symptoms, anxiety, perceptual disorders, weight loss, EEG changes, dose dependence, drug discontinuation
- MeSH terms
- Adult, Anxiety, Benzodiazepines, Body Weight, Electroencephalography, Evoked Potentials, Auditory, Female, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Substance Withdrawal Syndrome, Time Factors, Anti-Anxiety Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.